DIFFERENCE IN BODY WEIGHT OF PERSONS WITH ENDOCRINE PATHOLOGY — PATIENTS OF ADVISORY POLYCLINIC INSTITUTIONS
DOI:
https://doi.org/10.21856/j-PEP.2014.4.02Keywords:
obesity, overweight, endocrine pathology, sexual features, the urban population, screeningAbstract
According to the results of measurement of height, weight and body mass index counting 730
residents of a large industrial city over 18 years, applied to the advisory clinic of endocrinology
profile, it was characterized the frequency of their normal weight, overweight and obesity based on
sexual characteristics and the nature of endocrine pathology. It was revealed that 49 % of men and
66 % of women with type 2 diabetes, 50 % of men and 82 % of women with hypothalamic-pituitary
dysfunction, 8 % of men and 35 % of women with thyroid disease, had obesity in varying degrees of
severity. It was concluded the need for further research in the direction of objective evaluation of
the degree of risk of cardiovascular disease and other debilitating pathologies development associated
with excess body weight, depending on the sex, body weight, the nature of endocrine pathology, as
well as to explore possible pathogenic factors contributing to the accumulation of excess fat tissue in
patients with various endocrine pathologies.
References
Zaharova SM, Savel’eva LF, Fadeeva MI. Ozhirenie
i Metabolizm 2013; 2:54-57.
WHO. Obesity: preventing and managing
the global epidemic, Geneva, 2004, available at: www.who.int /nutrition /publications/obesity/WHO_TRS_894/en/. ˜
Pinhasov BB, Seljatickaja VG, Shorin JuP, et al.
Fundamental’nye Issledovanija 2011; 9:279-282.
Dreval’ AV, Misnikova IV, Barsukov IA. Terapevt
Arh 2009; 10:34-38.
Ozhirenie: jetiologija, patogenez, klinicheskie aspekty, pod red. Dedova II, Mel’nichenko GA,
Moskva, 2006: 456 p.
Kravchun NA, Polozova LG, Popova SS, et al. Mezhdunar Jendokrinol Zhurn 2014; 2(58): 81-84.
WHO. Controlling the Global Obesity Epidemic,
Geneva, 2002: 2013-2017.
Lakin GF. Biometrija, Moskva, 1990: 351 p.
Misjura EV, Il’ina IM, Romanova IP, et al. Probl
Endokryn Patologii’ 2014;1:24-31.